ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/12/2026
Back to search
Official data from USPTO
ROCKETVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/14/2026
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
11/04/2022
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
03/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
CH
Examiner
LEE, DOUGLAS
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ROCKETVAX" and stylized DNA double helix strands.
Holders and representatives
Holders
RocketVax AG
Representatives
Dwayne K. Goetzel Kowert, Hood, Munyon, Rankin & Goetzel,
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals; chemical preparations for scientific purposes; active chemical ingredients used in the manufacture of anti-cancer drugs
Class 5
Pharmaceutical productssubstances and preparations in particular for the prevention and treatment of infectious and cancerous diseases; vaccinesin particular viral and DNA-based and RNA-based vaccines; preparations for vaccines; adjuvants and additives for vaccines; additives for vaccines; biochemical substances for medical or veterinary usefor the prevention and treatment of infectious and cancerous diseases; synthetic DNA for medical or veterinary usefor the prevention and treatment of infectious and cancerous diseases; pharmaceutical diagnostic agents for medical use; pharmaceutical preparations and compositions for cancer treatment and cancer prevention
Class 42
Research and development in the fields of biologypharmacyimmunologyoncologyDNA-based technologiesgenetic engineering and vaccines; scientific research and development for medical purposes in the field of cancerous diseases; DNA verification in the nature of DNA screening for scientific research purposes; conducting and evaluation of scientific feasibility studiesin particular medical and pharmaceutical studies; development of diagnostic methods and testing procedures; preparation of scientific reports; advice concerning all the aforesaid services
Class 44
Medical services; pharmaceutical compounding consultant services; medical and pharmaceutical compounding services; preparation of medical and pharmaceutical reports with respect to treatment of individuals; performing RNA and DNA analyses for medical and veterinary purposes relating to the treatment of patients; conducting medical analysis relating to the treatment of patients; medical testing for diagnostic or treatment purposes; providing information in the field of cancer preventionscreeningdiagnosis and treatment; advice concerning all the aforesaid services
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2024
FIMP
FINAL DISPOSITION PROCESSED
07/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2023
RFNT
REFUSAL PROCESSED BY IB
10/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/15/2023
RFRR
REFUSAL PROCESSED BY MPU
09/15/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/26/2023
CNRT
NON-FINAL ACTION WRITTEN
08/25/2023
DOCK
ASSIGNED TO EXAMINER
08/21/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2023
Continuous trademark protection
Get notified about every new filing that threatens ROCKETVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.